Home › Major Depressive Disorder › Illinois › Chicago
Pag-aaral pangklinika para sa Major Depressive Disorder sa Chicago, IL
Isang pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Nagre-recruitPhase 3
- Charter Research - Chicago, Chicago
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Nagre-recruitPhase 3
- Chicago Research Center, Chicago
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Nagre-recruitPhase 3
- Northwestern University, Chicago
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Nagre-recruitPhase 2
- Chicago Research Center, Chicago
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Nagre-recruitPhase 3
- Rush University, Chicago
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Nagre-recruitPhase 3
- Vanda Investigational Site, Chicago
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Nagre-recruitPhase 2
- Draig Clinical Site, Chicago
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Nagre-recruit
- Rush University Medical Center, Chicago
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Nagre-recruitPhase 3
- Uptown Research Institute, Chicago
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Nagre-recruitPhase 2
- EmVenio Research, Chicago
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Nagre-recruitPhase 3
- Clinical Research Site, Chicago
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Nagre-recruitPhase 2
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Nagre-recruit
- University of Illinois at Chicago, Chicago
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Nagre-recruitPhase 2
- Pillar Clinical Research LLC, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Nagre-recruitObservasyonal na pag-aaral
- University of Chicago Medical Center, Chicago
Study of ALTO-300 in MDD
Nagre-recruitPhase 2
- Site 310, Chicago
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Nagre-recruitPhase 4
- Clinical Research Site, Chicago
Pag-aaral para sa Major Depressive Disorder sa ibang lungsod
- New York City, NY37 pag-aaral
- Boston, MA31 pag-aaral
- Atlanta, GA25 pag-aaral
- Philadelphia, PA23 pag-aaral
- Orlando, FL19 pag-aaral
- Miami, FL18 pag-aaral
- Tampa, FL17 pag-aaral
- Houston, TX16 pag-aaral
- San Diego, CA16 pag-aaral
- Little Rock, AR14 pag-aaral
- Orange, CA13 pag-aaral
- Austin, TX13 pag-aaral
Iba pang pag-aaral sa Chicago
- Non-Small Cell Lung Cancer61 pag-aaral
- Kanser sa Suso58 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Metastatic Cancer45 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Obesity41 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Stroke34 pag-aaral
- Colorectal Cancer33 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Overweight28 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.